Metabolomics for informing adverse outcome pathways: Androgen receptor activation and the pharmaceutical spironolactone

類似資料

• Leveraging existing data for prioritization of the ecological risks of human and veterinary pharmaceuticals to aquatic organisms
  著者:: LaLone, Carlie A., 等
  出版事項: (2014)
• Cell-Based Metabolomics for Untargeted Screening and Prioritization of Vertebrate-Active Stressors in Streams Across the United States
  著者:: Collette, TW, 等
  出版事項: (2019)
• Adverse Outcome Pathway Network-Based Assessment of the Interactive Effects of an Androgen Receptor Agonist and an Aromatase Inhibitor on Fish Endocrine Function
  著者:: Ankley, Gerald T., 等
  出版事項: (2020)
• High-resolution mass spectrometry of skin mucus for monitoring physiological impacts and contaminant biotransformation products in fathead minnows exposed to wastewater effluent
  著者:: Mosley, J. D., 等
  出版事項: (2017)
• PRACTICAL APPROACHES TO ADVERSE OUTCOME PATHWAY (AOP) DEVELOPMENT AND WEIGHT OF EVIDENCE EVALUATION AS ILLUSTRATED BY ECOTOXICOLOGICAL CASE STUDIES
  著者:: Fay, Kellie A., 等
  出版事項: (2017)